Pan Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 10
- Oncology 41
- Co-authors
- Nan Wu (16 shared papers)Shuanglong Xiong (7 shared papers)Hua Feng (4 shared papers)Bin Liao (11 shared papers)Junwei Wang (5 shared papers)Chunni Wang (1 shared paper)Yibo Gao (2 shared papers)Ning Li (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Frontiers in Oncology (5 papers)Frontiers in Medicine (4 papers)Oncotarget (4 papers)Cell Death and Disease (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Pan Wang
162 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 136
- Cancer Research 660
- Molecular Biology 1.1k
- Oncology 432
- Immunology 287
- Genetics 136
Countries citing papers authored by Pan Wang
This map shows the geographic impact of Pan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Wang more than expected).
Fields of papers citing papers by Pan Wang
This network shows the impact of papers produced by Pan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Wang. The network helps show where Pan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Pan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 123 | |
| 2 | 2017 | 84 | |
| 3 | 2020 | 61 | |
| 4 | 2019 | 61 | |
| 5 | 2017 | 53 | |
| 6 | 2012 | 49 | |
| 7 | 2016 | 48 | |
| 8 | 2021 | 47 | |
| 9 | 2019 | 44 | |
| 10 | 2021 | 44 | |
| 11 | 2015 | 39 | |
| 12 | 2020 | 39 | |
| 13 | 2017 | 39 | |
| 14 | 2017 | 38 | |
| 15 | 2019 | 37 | |
| 16 | 2023 | 37 | |
| 17 | 2021 | 36 | |
| 18 | 2018 | 34 | |
| 19 | 2023 | 33 | |
| 20 | 2017 | 33 |
About Pan Wang
Pan Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Neurology, having authored 179 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (13 papers), Cancer, Hypoxia, and Metabolism (12 papers), Head and Neck Cancer Studies (11 papers), Head and Neck Surgical Oncology (11 papers), Circular RNAs in diseases (10 papers), Ovarian cancer diagnosis and treatment (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). The work is most often cited by research in Cancer Research (660 citations), Molecular Biology (1.1k citations), Oncology (432 citations), Immunology (287 citations) and Genetics (136 citations). Pan Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Nan Wu, Shuanglong Xiong, Hua Feng, Bin Liao, Junwei Wang, Chunni Wang, Yibo Gao, Ning Li, Zhenlin Yang and Renda Li. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Frontiers in Medicine, Oncotarget and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.